Treatment-resistant Churg-Strauss syndrome: progression after five years using rituximab
Nefrologia. 2013;33(5):737-9.
doi: 10.3265/Nefrologia.pre2013.May.12101.
[Article in
English,
Spanish]
No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use*
-
Biopsy
-
Churg-Strauss Syndrome / drug therapy*
-
Churg-Strauss Syndrome / immunology
-
Churg-Strauss Syndrome / therapy
-
Combined Modality Therapy
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / pharmacology
-
Cyclophosphamide / therapeutic use
-
Disease Progression
-
Drug Resistance
-
Glomerulonephritis / etiology
-
Glomerulonephritis / pathology
-
Glomerulonephritis / therapy
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Kidney / pathology
-
Male
-
Methylprednisolone / pharmacology
-
Methylprednisolone / therapeutic use
-
Plasmapheresis
-
Prednisone / pharmacology
-
Prednisone / therapeutic use
-
Remission Induction
-
Renal Dialysis
-
Rituximab
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Immunosuppressive Agents
-
Rituximab
-
Cyclophosphamide
-
Prednisone
-
Methylprednisolone